WDNA vs. NTSX
WDNA (WisdomTree BioRevolution Fund) and NTSX (WisdomTree U.S. Efficient Core Fund) are both exchange-traded funds - WDNA is a Health & Biotech Equities fund tracking the WisdomTree BioRevolution Index, while NTSX is a Diversified Portfolio fund actively managed by WisdomTree. WDNA is passively managed, while NTSX is actively managed. Over the past 5 years, WDNA returned -4.78%/yr vs 9.87%/yr for NTSX. A 0.65 correlation means they provide meaningful diversification when combined. WDNA charges 0.45%/yr vs 0.20%/yr for NTSX.
Performance
WDNA vs. NTSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WDNA achieves a 8.96% return, which is significantly lower than NTSX's 9.50% return.
WDNA
- 1D
- 2.94%
- 1M
- 2.56%
- YTD
- 8.96%
- 6M
- 10.44%
- 1Y
- 50.50%
- 3Y*
- 3.54%
- 5Y*
- -4.78%
- 10Y*
- —
NTSX
- 1D
- 0.81%
- 1M
- 4.30%
- YTD
- 9.50%
- 6M
- 8.89%
- 1Y
- 25.65%
- 3Y*
- 19.75%
- 5Y*
- 9.87%
- 10Y*
- —
WDNA vs. NTSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
WDNA WisdomTree BioRevolution Fund | 8.96% | 22.68% | -14.18% | -2.07% | -26.29% | -5.27% |
NTSX WisdomTree U.S. Efficient Core Fund | 9.50% | 18.82% | 20.20% | 22.70% | -25.84% | 13.31% |
Correlation
The correlation between WDNA and NTSX is 0.53, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.53 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.59 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.65 |
Correlation (All Time) Calculated using the full available price history since Jun 4, 2021 | 0.65 |
The correlation between WDNA and NTSX shifts across timeframes, from 0.53 (1 year) to 0.65 (5 years), reflecting how their relationship changes across market environments.
WDNA vs. NTSX - Sectors Allocation Comparison
Sectors
WDNA
NTSX
Healthcare
Basic Materials
Consumer Defensive
Energy
Communication Services
-
Consumer Cyclical
-
Financial Services
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
WDNA
NTSX
Basic Materials
WDNA
NTSX
Consumer Defensive
WDNA
NTSX
Energy
WDNA
NTSX
Communication Services
WDNA
-
NTSX
Consumer Cyclical
WDNA
-
NTSX
Financial Services
WDNA
-
NTSX
Industrials
WDNA
-
NTSX
Real Estate
WDNA
-
NTSX
Technology
WDNA
-
NTSX
Utilities
WDNA
-
NTSX
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WDNA vs. NTSX — Risk / Return Rank
WDNA
NTSX
WDNA vs. NTSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and WisdomTree U.S. Efficient Core Fund (NTSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WDNA | NTSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.11 | ||
| Sortino ratioReturn per unit of downside risk | 0.00 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.38 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 4.34 | 2.81 | +1.53 |
| Martin ratioReturn relative to average drawdown | 9.85 | 12.44 | -2.59 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| WDNA | NTSX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.98 | 2.09 | -0.11 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.19 | 0.58 | -0.77 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.19 | 0.72 | -0.91 |
Drawdowns
WDNA vs. NTSX - Drawdown Comparison
The maximum WDNA drawdown since its inception was -58.87%, which is greater than NTSX's maximum drawdown of -31.34%. Use the drawdown chart below to compare losses from any high point for WDNA and NTSX.
Loading charts...
Drawdown Indicators
| WDNA | NTSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.87% | -31.34% | -27.53% |
Max Drawdown (1Y)Largest decline over 1 year | -11.70% | -9.16% | -2.54% |
Max Drawdown (3Y)Largest decline over 3 years | -38.25% | -16.82% | -21.43% |
Max Drawdown (5Y)Largest decline over 5 years | -58.87% | -31.34% | -27.53% |
Current DrawdownCurrent decline from peak | -29.86% | -0.25% | -29.61% |
Average DrawdownAverage peak-to-trough decline | -35.64% | -6.79% | -28.85% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.14% | 2.07% | +3.07% |
Volatility
WDNA vs. NTSX - Volatility Comparison
WisdomTree BioRevolution Fund (WDNA) has a higher volatility of 7.35% compared to WisdomTree U.S. Efficient Core Fund (NTSX) at 3.38%. This indicates that WDNA's price experiences larger fluctuations and is considered to be riskier than NTSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WDNA | NTSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.35% | 3.38% | +3.97% |
Volatility (6M)Calculated over the trailing 6-month period | 16.59% | 9.61% | +6.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.66% | 12.32% | +13.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.08% | 17.04% | +8.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.07% | 18.27% | +6.80% |
WDNA vs. NTSX - Expense Ratio Comparison
WDNA has a 0.45% expense ratio, which is higher than NTSX's 0.20% expense ratio.
Dividends
WDNA vs. NTSX - Dividend Comparison
WDNA's dividend yield for the trailing twelve months is around 4.19%, more than NTSX's 1.07% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
NTSX WisdomTree U.S. Efficient Core Fund | 1.07% | 1.14% | 1.14% | 1.21% | 1.36% | 0.82% | 0.92% | 1.42% | 0.62% |
WDNA WisdomTree BioRevolution Fund | 4.19% | 4.57% | 0.75% | 0.80% | 0.38% | 0.10% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
WDNA and NTSX have a correlation of 0.53, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
WDNA has higher volatility (7.35%) compared to NTSX (3.38%). In terms of maximum drawdown, WDNA dropped -58.87% vs NTSX's -31.34%.
On 5-year performance, NTSX leads with 9.87% vs -4.78% for WDNA. On fees, NTSX is cheaper at 0.20% per year. On volatility, NTSX has been the lower-risk option at 3.38%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, NTSX has performed better with a 9.87% return vs -4.78%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
NTSX is cheaper with a 0.20% expense ratio, compared with 0.45% for WDNA.
WDNA has the higher dividend yield at 4.19%, compared with 1.07% for NTSX.
WDNA is categorized as Health & Biotech Equities, while NTSX is Diversified Portfolio. Their fees differ too: 0.45% for WDNA and 0.20% for NTSX.
NTSX currently has the higher Sharpe Ratio (2.09 vs 1.98), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for WDNA and NTSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer